This bill would decouple New Jersey from IRC Section 280E. This section forbids companies engaged in illegal drug activities from deducting business expenses. 280E has a negative impact on New Jersey companies working in the medicinal market and will hurt businesses that will be involved with the recreational cannabis industry (if it ever becomes legal in New Jersey). Decoupling would eliminate this burden for state taxation purposes.
Read more cannabis-related news